growing

Infrastructure for Medication Adherence Prediction & Intervention

ML model that predicts which patients are at high risk for medication non-adherence and triggers targeted interventions to improve compliance.

Last updated: February 2026Data current as of: February 2026

Analysis based on CMC Framework: 730 capabilities, 560+ vendors, 7 industries.

T2·Workflow-level automation

Key Finding

Medication Adherence Prediction & Intervention requires CMC Level 3 Capture for successful deployment. The typical pharmacy operations organization in Healthcare faces gaps in 0 of 6 infrastructure dimensions.

Structural Coherence Requirements

The structural coherence levels needed to deploy this capability.

Requirements are analytical estimates based on infrastructure analysis. Actual needs may vary by vendor and implementation.

Formality
L2
Capture
L3
Structure
L3
Accessibility
L3
Maintenance
L2
Integration
L3

Why These Levels

The reasoning behind each dimension requirement.

Formality: L2

Medication adherence prediction operates against a partially formalized knowledge base: prescription fill policies and refill protocols exist as documented procedures, but the clinical decision logic for intervention type matching (when to recommend pill packaging vs. reminder calls vs. pharmacist counseling for a specific patient profile) is largely undocumented, reflecting individualized pharmacist judgment. Documentation practice exists for adherence measurement methodology (PDC calculations) but intervention protocols and personalization criteria are not systematically documented.

Capture: L3

Adherence prediction requires systematic capture of prescription fill events, refill request timing, PDC calculations, prior intervention attempts, and outcomes of previous outreach. EHR and pharmacy management systems capture fill history through defined workflows. Template-driven documentation ensures prior intervention attempts (call attempts, outcomes, patient responses) are logged with consistent fields needed to train the prediction model and avoid duplicate outreach to the same patient.

Structure: L3

Adherence prediction modeling requires consistent schema across patient records: medication list with NDC, fill dates, days supply, PDC calculations, diagnosis codes, demographic fields, and prior intervention history with outcomes. RxNorm and ICD-10 codes provide structured taxonomy for medications and conditions. All patient records must share these fields to enable comparative risk scoring—identifying which patient profiles correlate with non-adherence across the population.

Accessibility: L3

The adherence prediction system requires API access to pharmacy fill data (internal and Surescripts external pharmacy claims), EHR (diagnoses, medication complexity, prior hospitalizations), and care management platforms (prior intervention history). These connections enable the model to assemble a complete adherence risk profile per patient. The existing EHR-to-pharmacy integration supports internal data access; Surescripts APIs enable external fill data that reveals adherence gaps invisible within the health system.

Maintenance: L2

Adherence prediction models and intervention protocols are updated on scheduled cycles—typically when adherence program reviews occur or when drug formulary changes affect the medication classes being monitored. The intervention matching logic (which patient profile gets which intervention type) isn't updated by clinical events but by periodic program evaluations. P&T committee quarterly meetings provide the governance mechanism, but adherence protocol updates lag evidence, consistent with an L2 maintenance posture.

Integration: L3

Medication adherence prediction requires API-based connections between the pharmacy fill system, EHR (diagnosis and medication complexity), care management platform (prior intervention tracking), and outreach systems (phone, portal, messaging). These connections enable the system to generate risk scores and trigger intervention workflows without manual data assembly. The existing closed-loop medication use process integration, supplemented by Surescripts API access for external fill data, provides the required connectivity.

What Must Be In Place

Concrete structural preconditions — what must exist before this capability operates reliably.

Primary Structural Lever

Whether operational knowledge is systematically recorded

The structural lever that most constrains deployment of this capability.

Whether operational knowledge is systematically recorded

  • Systematic capture of prescription fill dates, refill gaps, pharmacy contact outcomes, and patient-reported barrier events into longitudinal adherence records with defined schema

How explicitly business rules and processes are documented

  • Documented workflow definitions for intervention pathways specifying trigger conditions, escalation steps, and outreach channel protocols for each adherence risk tier

How data is organized into queryable, relational formats

  • Formal classification of adherence barriers by category (cost, complexity, belief, access) with validated mappings to intervention type and escalation severity

Whether systems expose data through programmatic interfaces

  • Self-service access layer exposing patient adherence risk scores and intervention histories to care coordinators and clinical pharmacists via role-based interfaces

Whether systems share data bidirectionally

  • Standard API connections to pharmacy dispensing systems, claims feeds, and patient communication platforms enabling end-to-end intervention tracking

How frequently and reliably information is kept current

  • Periodic review of intervention effectiveness metrics with feedback loop updating risk model features when population adherence patterns shift

Common Misdiagnosis

Programs treat adherence prediction as a data science problem and build sophisticated risk scores while intervention workflows remain undocumented — a high-accuracy prediction model produces no outcome improvement if the triggered outreach steps are inconsistently executed.

Recommended Sequence

Start with establishing systematic, longitudinal capture of fill and refill events before intervention workflow work, since the prediction model requires sufficient adherence history to distinguish at-risk patients from those with temporary gaps.

Gap from Pharmacy Operations Capacity Profile

How the typical pharmacy operations function compares to what this capability requires.

Pharmacy Operations Capacity Profile
Required Capacity
Formality
L4
L2
READY
Capture
L4
L3
READY
Structure
L4
L3
READY
Accessibility
L3
L3
READY
Maintenance
L3
L2
READY
Integration
L3
L3
READY

More in Pharmacy Operations

Frequently Asked Questions

What infrastructure does Medication Adherence Prediction & Intervention need?

Medication Adherence Prediction & Intervention requires the following CMC levels: Formality L2, Capture L3, Structure L3, Accessibility L3, Maintenance L2, Integration L3. These represent minimum organizational infrastructure for successful deployment.

Which industries are ready for Medication Adherence Prediction & Intervention?

Based on CMC analysis, the typical Healthcare pharmacy operations organization is not structurally blocked from deploying Medication Adherence Prediction & Intervention. All dimensions are within reach.

Ready to Deploy Medication Adherence Prediction & Intervention?

Check what your infrastructure can support. Add to your path and build your roadmap.